Trastuzumab Deruxtecan Bests Chemotherapy-Based Regimens in Those Previously Treated With T-DM1
December 8th 2022DESTINY-Breast02 clinical trial results show trastuzumab deruxtecan demonstrated a clinically meaningful and statistically significant improvement in progression-free and overall survival.
Read More
Interim Analysis Updates Adjuvant Abemaciclib Plus Endocrine Therapy Study
December 7th 2022Phase 3 monarchE trial assesses distant relapse free-survival, invasive disease-free survival, and overall survival for the treatment of HR-positive/HER2-negative-, node-positive, high-risk early breast cancer.
Read More
Expert Discusses What Pharmacists Should Know About Herbal Supplements for Dementia
December 6th 2022Kalin Clifford, associate professor in the Geriatrics Division at Texas Tech University Health Sciences Center in the Jerry H. Hodge School of Pharmacy, discusses the potential benefits of herbal supplements for dementia care.
Watch
Successful Career Ladder Helps Retain Pharmacy Technicians
December 6th 2022Tom Greenlee, retail pharmacy manager at the University of Missouri Health Care, and Kayla Hodges, 340B Analyst in Pharmacy Business at the University of Missouri Health Care, discuss how a successful career ladder can help retain pharmacy technicians.
Watch